These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18854695)

  • 61. Cigarette smoking and thyroid eye disease: a systematic review.
    Thornton J; Kelly SP; Harrison RA; Edwards R
    Eye (Lond); 2007 Sep; 21(9):1135-45. PubMed ID: 16980921
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and Safety of Immunosuppressive Agents for Thyroid Eye Disease.
    Strianese D
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S56-S59. PubMed ID: 29923966
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Redox mechanisms in autoimmune thyroid eye disease.
    Buonfiglio F; Ponto KA; Pfeiffer N; Kahaly GJ; Gericke A
    Autoimmun Rev; 2024 May; 23(5):103534. PubMed ID: 38527685
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Extrathyroidal manifestations of thyroid disease: thyroid ophthalmopathy.
    Parmar H; Ibrahim M
    Neuroimaging Clin N Am; 2008 Aug; 18(3):527-36, viii-ix. PubMed ID: 18656033
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management of patients in a combined thyroid eye clinic in secondary care.
    Benzimra JD; Quinn AG; Kersey T; McGrane D; Goss L; Vaidya B
    Int Ophthalmol; 2014 Feb; 34(1):1-6. PubMed ID: 23549634
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Orbit and orbital apex.
    Robinson D; Wilcsek G; Sacks R
    Otolaryngol Clin North Am; 2011 Aug; 44(4):903-22, viii. PubMed ID: 21819879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thyroid eye disease survey: An anonymous web-based survey in the Indian subcontinent.
    Pradhan A; Ganguly A; Naik MN; Nair AG; Desai S; Rath S
    Indian J Ophthalmol; 2020 Aug; 68(8):1609-1614. PubMed ID: 32709788
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A data-driven approach for the discovery of biomarkers associated with thyroid eye disease.
    Zou H; Xu W; Wang Y; Wang Z
    BMC Ophthalmol; 2021 Apr; 21(1):166. PubMed ID: 33832456
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comment on 'Acute thyroid eye disease (TED): principles of medical and surgical management'.
    Litwin AS; Malhotra R
    Eye (Lond); 2014 May; 28(5):632. PubMed ID: 24603423
    [No Abstract]   [Full Text] [Related]  

  • 71. Medical treatment in thyroid eye disease in 2020.
    Khong JJ; McNab A
    Br J Ophthalmol; 2021 Mar; 105(3):299-305. PubMed ID: 32447327
    [TBL] [Abstract][Full Text] [Related]  

  • 72. B-cell targeted therapy with rituximab for thyroid eye disease: closer to the clinic.
    Shen S; Chan A; Sfikakis PP; Hsiu Ling AL; Detorakis ET; Boboridis KG; Mavrikakis I
    Surv Ophthalmol; 2013; 58(3):252-65. PubMed ID: 23253433
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quality of life in thyroid eye disease: impact of quality of care.
    Estcourt S; Quinn AG; Vaidya B
    Eur J Endocrinol; 2011 May; 164(5):649-55. PubMed ID: 21367964
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predictive markers for anti-inflammatory treatment response in thyroid eye disease.
    Zhang H; Fan J; Qu J; Han Q; Zhou H; Song X
    Front Endocrinol (Lausanne); 2023; 14():1292519. PubMed ID: 38111706
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey.
    Estcourt S; Hickey J; Perros P; Dayan C; Vaidya B
    Eur J Endocrinol; 2009 Sep; 161(3):483-7. PubMed ID: 19542244
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A New Era in the Treatment of Thyroid Eye Disease.
    Patel A; Yang H; Douglas RS
    Am J Ophthalmol; 2019 Dec; 208():281-288. PubMed ID: 31377284
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease.
    Fayers T; Dolman PJ
    Br J Ophthalmol; 2011 Dec; 95(12):1670-4. PubMed ID: 21951566
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bilateral inferior oblique enlargement in thyroid eye disease.
    Vahdani K; Rose GE
    J AAPOS; 2021 Apr; 25(2):112-113. PubMed ID: 33338584
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Medical management of thyroid eye disease.
    Yang DD; Gonzalez MO; Durairaj VD
    Saudi J Ophthalmol; 2011 Jan; 25(1):3-13. PubMed ID: 23960897
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical challenges of thyroid eye disease in HIV-positive patients on highly active antiretroviral therapy.
    Edmunds MR; Mellington F; Ford RL; Torlinska B; Manavi K; Boelaert K
    J Clin Endocrinol Metab; 2015 Mar; 100(3):779-87. PubMed ID: 25584718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.